Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
483 | 3 | ESSENTIAL THROMBOCYTHEMIA//THROMBOPOIETIN//HEMATOLOGY | 24292 |
1046 | 2 | ESSENTIAL THROMBOCYTHEMIA//THROMBOPOIETIN//POLYCYTHEMIA VERA | 10413 |
109 | 1 | ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS | 4414 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ESSENTIAL THROMBOCYTHEMIA | authKW | 3148244 | 13% | 79% | 560 |
2 | POLYCYTHEMIA VERA | authKW | 2502251 | 12% | 69% | 509 |
3 | MYELOFIBROSIS | authKW | 2148336 | 11% | 61% | 495 |
4 | MYELOPROLIFERATIVE NEOPLASMS | authKW | 1944156 | 9% | 71% | 386 |
5 | JAK2V617F | authKW | 1102422 | 4% | 83% | 186 |
6 | MYELOPROLIFERATIVE DISORDERS | authKW | 999128 | 6% | 50% | 282 |
7 | PRIMARY MYELOFIBROSIS | authKW | 969599 | 4% | 83% | 164 |
8 | ESSENTIAL THROMBOCYTHAEMIA | authKW | 776770 | 3% | 81% | 134 |
9 | JAK2 | authKW | 694661 | 6% | 38% | 259 |
10 | ANAGRELIDE | authKW | 641755 | 2% | 87% | 103 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Hematology | 182952 | 61% | 1% | 2707 |
2 | Oncology | 7557 | 23% | 0% | 1009 |
3 | Pathology | 1581 | 6% | 0% | 260 |
4 | Medicine, General & Internal | 991 | 8% | 0% | 375 |
5 | Peripheral Vascular Diseases | 622 | 4% | 0% | 186 |
6 | Medicine, Research & Experimental | 233 | 4% | 0% | 175 |
7 | Medical Laboratory Technology | 157 | 1% | 0% | 55 |
8 | Transplantation | 81 | 1% | 0% | 57 |
9 | Cell Biology | 45 | 4% | 0% | 172 |
10 | Cell & Tissue Engineering | 31 | 0% | 0% | 15 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HEMATOL BLOOD COAGULAT | 257328 | 1% | 69% | 52 |
2 | STUDY MYELOFIBROSIS | 244265 | 1% | 67% | 51 |
3 | HEMATOL | 140615 | 23% | 2% | 1014 |
4 | INNOVAT MYELOPROLIFERAT NEOPLASMS | 71976 | 0% | 92% | 11 |
5 | LEUKEMIA | 55435 | 3% | 5% | 142 |
6 | GOODHEART | 51386 | 0% | 60% | 12 |
7 | HEMATOL L | 50800 | 0% | 65% | 11 |
8 | CONGIUNTO MMPC | 50759 | 0% | 89% | 8 |
9 | THROMBOCYTHEMIA VERA STUDY GRP | 49968 | 0% | 100% | 7 |
10 | LEUKEMIA SERV | 46710 | 1% | 14% | 47 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BRITISH JOURNAL OF HAEMATOLOGY | 41612 | 6% | 2% | 283 |
2 | AMERICAN JOURNAL OF HEMATOLOGY | 40738 | 4% | 3% | 186 |
3 | EUROPEAN JOURNAL OF HAEMATOLOGY | 40433 | 3% | 4% | 149 |
4 | BLOOD | 28720 | 9% | 1% | 376 |
5 | ANNALS OF HEMATOLOGY | 24361 | 3% | 3% | 114 |
6 | CURRENT HEMATOLOGIC MALIGNANCY REPORTS | 22024 | 1% | 9% | 33 |
7 | HAEMATOLOGICA | 16521 | 2% | 2% | 94 |
8 | LEUKEMIA RESEARCH | 16358 | 3% | 2% | 119 |
9 | LEUKEMIA | 15004 | 3% | 2% | 128 |
10 | LEUKEMIA & LYMPHOMA | 13554 | 3% | 2% | 122 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ESSENTIAL THROMBOCYTHEMIA | 3148244 | 13% | 79% | 560 | Search ESSENTIAL+THROMBOCYTHEMIA | Search ESSENTIAL+THROMBOCYTHEMIA |
2 | POLYCYTHEMIA VERA | 2502251 | 12% | 69% | 509 | Search POLYCYTHEMIA+VERA | Search POLYCYTHEMIA+VERA |
3 | MYELOFIBROSIS | 2148336 | 11% | 61% | 495 | Search MYELOFIBROSIS | Search MYELOFIBROSIS |
4 | MYELOPROLIFERATIVE NEOPLASMS | 1944156 | 9% | 71% | 386 | Search MYELOPROLIFERATIVE+NEOPLASMS | Search MYELOPROLIFERATIVE+NEOPLASMS |
5 | JAK2V617F | 1102422 | 4% | 83% | 186 | Search JAK2V617F | Search JAK2V617F |
6 | MYELOPROLIFERATIVE DISORDERS | 999128 | 6% | 50% | 282 | Search MYELOPROLIFERATIVE+DISORDERS | Search MYELOPROLIFERATIVE+DISORDERS |
7 | PRIMARY MYELOFIBROSIS | 969599 | 4% | 83% | 164 | Search PRIMARY+MYELOFIBROSIS | Search PRIMARY+MYELOFIBROSIS |
8 | ESSENTIAL THROMBOCYTHAEMIA | 776770 | 3% | 81% | 134 | Search ESSENTIAL+THROMBOCYTHAEMIA | Search ESSENTIAL+THROMBOCYTHAEMIA |
9 | JAK2 | 694661 | 6% | 38% | 259 | Search JAK2 | Search JAK2 |
10 | ANAGRELIDE | 641755 | 2% | 87% | 103 | Search ANAGRELIDE | Search ANAGRELIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |